Skip to Content
Merck

Key Documents

View All Documentation

Skip To

PHR1823

Supelco

Budesonide Related Compound L

Pharmaceutical Secondary Standard; Certified Reference Material

Synonym(s):

16α,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione, 16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione, Budesonide Impurity L (PhEur), 11-Ketobudesonide

Sign Into View Organizational & Contract Pricing

About This Item

Empirical Formula (Hill Notation):
C25H32O6
CAS Number:
216453-74-6
Molecular Weight:
428.52
UNSPSC Code:
41116107
NACRES:
NA.24
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

certified reference material
pharmaceutical secondary standard

Quality Level

300

Agency

traceable to USP 1078289

description

Pharmaceutical Secondary Standard; Certified Reference Material

API family

budesonide

CofA

current certificate can be downloaded

packaging

pkg of 50 mg

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

pharmaceutical (small molecule)

format

neat

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
107828910782451078267
Budesonide Related Compound L Pharmaceutical Secondary Standard; Certified Reference Material

PHR1823

Budesonide Related Compound L

USP

1078289

Budesonide Related Compound L

USP

1078245

Budesonide Related Compound E

USP

1078267

Budesonide Related Compound G

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

technique(s)

-

technique(s)

-

technique(s)

-

format

neat

format

neat

format

neat

format

neat

Quality Level

300

Quality Level

-

Quality Level

-

Quality Level

-

grade

certified reference material, pharmaceutical secondary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

General description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Application

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Footnote

To see an example of a Certificate of Analysis for this material enter LRAB0431 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

related product

Product No.
Description
Pricing

PHR1178

Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material

B1157300

Budesonide, European Pharmacopoeia (EP) Reference Standard

Y0001148

Budesonide for system suitability, European Pharmacopoeia (EP) Reference Standard

1078201

Budesonide, United States Pharmacopeia (USP) Reference Standard

1078289

Budesonide Related Compound L, United States Pharmacopeia (USP) Reference Standard

1078267

Budesonide Related Compound G, United States Pharmacopeia (USP) Reference Standard

1078245

Budesonide Related Compound E, United States Pharmacopeia (USP) Reference Standard

PHR1822

Budesonide Related Compound G, Pharmaceutical Secondary Standard; Certified Reference Material

BP793

Budesonide, British Pharmacopoeia (BP) Reference Standard

BP894

Budesonide impurity standard, British Pharmacopoeia (BP) Reference Standard

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Elson C Santos et al.
Journal of nanoscience and nanotechnology, 14(6), 4590-4594 (2014-04-18)
The system proposed consists of a flagellum relaxing around a static carbon nanowire to mimics behavior of a natural flagellum moving with damped harmonic motion along a wire under van der Waals and electrostatic forces. This flagellum is composed of
B Franz Lang et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(16), 5926-5931 (2014-04-09)
Programmed translational bypassing is a process whereby ribosomes "ignore" a substantial interval of mRNA sequence. Although discovered 25 y ago, the only experimentally confirmed example of this puzzling phenomenon is expression of the bacteriophage T4 gene 60. Bypassing requires translational
Marshall W Bowles et al.
Science (New York, N.Y.), 344(6186), 889-891 (2014-05-09)
Sulfate reduction is a globally important redox process in marine sediments, yet global rates are poorly quantified. We developed an artificial neural network trained with 199 sulfate profiles, constrained with geomorphological and geochemical maps to estimate global sulfate-reduction rate distributions.
Clarissa Gillmann et al.
International journal of radiation oncology, biology, physics, 88(5), 1136-1141 (2014-03-26)
To compare the relative biological effectiveness (RBE)-weighted tolerance doses for temporal lobe reactions after carbon ion radiation therapy using 2 different versions of the local effect model (LEM I vs LEM IV) for the same patient collective under identical conditions.
Chi-lai Ho et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 55(5), 749-752 (2014-03-29)
We prospectively compared (11)C-acetate with (18)F-FDG in a PET/CT evaluation of multiple myeloma (MM), specifically on diagnostic accuracy, identification of high-risk patients, and monitoring of treatment response. Dual-tracer PET/CT was performed on 35 pathologically and clinically confirmed and untreated patients
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service